Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.44% |
| 2 | Technology | 18.54% |
| 3 | Consumer Discretionary | 14.07% |
| 4 | Industrials | 10.25% |
| 5 | Financials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACC
1326
DELISTED
American Campus Communities, Inc.
ACC
| $1.63M | ﹤0.01% |
39,448
-6,357
| -14% | -$264K |
|
|
ASRT
1327
DELISTED
Assertio
ASRT
| $1.62M | ﹤0.01% |
7,496
+3,542
| +90% | +$1.06M |
|
1328
Pegasystems
PEGA
$5.57B
| $1.61M | ﹤0.01% |
67,194
+48,922
| +268% | +$1.28M |
|
1329
CBIZ
CBZ
$2.96B
| $1.6M | ﹤0.01% |
81,444
-23,070
| -22% | -$493K |
|
1330
Blackbaud
BLKB
$2.15B
| $1.59M | ﹤0.01% |
25,355
-9,212
| -27% | -$663K |
|
1331
Gray Television
GTN
$514M
| $1.59M | ﹤0.01% |
108,195
+8,978
| +9% | +$156K |
|
1332
Carpenter Technology
CRS
$23.9B
| $1.58M | ﹤0.01% |
44,495
+28,681
| +181% | +$1.29M |
|
1333
Brady Corp
BRC
$4.38B
| $1.58M | ﹤0.01% |
36,328
-2,331
| -6% | -$97.1K |
|
1334
Customers Bancorp
CUBI
$2.65B
| $1.58M | ﹤0.01% |
86,774
-30,733
| -26% | -$615K |
|
|
EBIX
1335
DELISTED
Ebix Inc
EBIX
| $1.58M | ﹤0.01% |
37,057
-10,527
| -22% | -$561K |
|
1336
HealthEquity
HQY
$8.75B
| $1.58M | ﹤0.01% |
26,427
-341
| -1% | -$27.5K |
|
|
RWT
1337
Redwood Trust
RWT
$597M
| $1.58M | ﹤0.01% |
104,562
-4,733
| -4% | -$76.4K |
|
|
SAFE
1338
Safehold
SAFE
$1.09B
| $1.56M | ﹤0.01% |
35,037
-15,521
| -31% | -$786K |
|
1339
Marten Transport
MRTN
$1.19B
| $1.56M | ﹤0.01% |
144,794
-140,518
| -49% | -$1.76M |
|
1340
GameStop
GME
$8.09B
| $1.56M | ﹤0.01% |
495,060
+169,672
| +52% | +$594K |
|
|
CNCE
1341
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.56M | ﹤0.01% |
124,394
-119,687
| -49% | -$1.65M |
|
|
FOLD
1342
DELISTED
Amicus Therapeutics
FOLD
| $1.55M | ﹤0.01% |
162,009
-39,946
| -20% | -$439K |
|
1343
Red Robin
RRGB
$183M
| $1.55M | ﹤0.01% |
58,041
+1,340
| +2% | +$45.1K |
|
1344
Martin Marietta Materials
MLM
$37.9B
| $1.55M | ﹤0.01% |
9,011
-22
| -0.2% | -$3.91K |
|
1345
Northern Oil and Gas
NOG
$2.8B
| $1.53M | ﹤0.01% |
67,816
-192,294
| -74% | -$5.65M |
|
1346
CF Industries
CF
$19.2B
| $1.53M | ﹤0.01% |
35,145
+11,956
| +52% | +$561K |
|
1347
Marcus Corp
MCS
$936M
| $1.53M | ﹤0.01% |
38,716
-4,001
| -9% | -$165K |
|
|
JHG
1348
DELISTED
Janus Henderson
JHG
| $1.52M | ﹤0.01% |
73,568
-27,292
| -27% | -$627K |
|
1349
MYR Group
MYRG
$4.68B
| $1.52M | ﹤0.01% |
54,026
+557
| +1% | +$17.2K |
|
1350
TransDigm Group
TDG
$66.1B
| $1.52M | ﹤0.01% |
4,472
+94
| +2% | +$32.3K |
|
Similar funds
Cliff Asness's Q4 2018 Portfolio in Review
As of Q4 2018, Cliff Asness held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Cliff Asness's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- Cliff Asness added most to Merck in Q4 2018, an estimated $354M increase.
- Cliff Asness's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- Cliff Asness fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- Cliff Asness's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- Cliff Asness opened 138 new positions and closed 217 in Q4 2018.
- Cliff Asness's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.